Geriatric Medicine in an Aging Society: Up for a Challenge? by Arduino A. Mangoni
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MEDICINE
SPECIALTY GRAND CHALLENGE ARTICLE
published: 29 April 2014
doi: 10.3389/fmed.2014.00010
Geriatric medicine in an aging society: up for a challenge?
Arduino A. Mangoni*
Department of Clinical Pharmacology, School of Medicine, Flinders Medical Centre, Flinders University, Adelaide, SA, Australia
*Correspondence: arduino.mangoni@flinders.edu.au
Edited by:
Graziano Onder, Università Cattolica del Sacro Cuore, Italy
Reviewed by:
Mirko Petrovic, Ghent University Hospital, Belgium
Keywords: aging, geriatric medicine, healthcare systems, independence, workforce
A progressive decrease in fertility, together
with lengthening life expectancy, has dri-
ven a reshaping in the age distribution of
the world population (1). The main con-
sequence of this reshaping is a progressive
increase in both the number and the rel-
ative proportion of older people in our
society. Current fertility rates in virtually
all developed countries are below replace-
ment levels, reflecting the significant soci-
etal, cultural, and lifestyle changes over the
last century. A faster decline in fertility
is occurring in developing countries. The
latter is anticipated to reduce global geo-
graphical differences in fertility rates. The
increase in life expectancy is related to a
number of factors such as improved socioe-
conomic conditions and access to health
services, early detection of disease condi-
tions, and improved short- and long-term
outcomes after an illness. Mean global life
expectancy has increased from 46.5 years
in 1950–1955 to 66.0 years in 2000–2005.
This increase has been more prominent in
less developed countries although signifi-
cant variation exists in these regions (2).
Notably, the relative gain in life expectancy
is also projected to increase at older age, i.e.,
by 27% at age 80, 19% at age 60, and only
9% at birth over the next 50 years. There-
fore, specific subgroups within the older
population, e.g., >80 years, are growing
particularly fast.
Geriatric Medicine, as a clinical and aca-
demic specialty in its own right, has signifi-
cantly expanded over the last 20 years, par-
ticularly in the UK, a number of Western
European countries, North America, Aus-
tralia, and New Zealand. A recent census
in the UK showed that Geriatric Medicine
consultants represent the largest specialty
group within the National Health Service
(n= 1,252; 10.2% of the total workforce)
(3). Moreover, the number of advanced
trainees in Geriatric Medicine has
increased from 433 in 2003 to 630 in 2013
(+45%). Professional national and inter-
national bodies, e.g., the British and Amer-
ican Geriatrics Societies and the European
Union Geriatric Medicine Society, have
played a significant role in promoting
the importance of a focused geriatric
assessment and a multidisciplinary patient-
centered approach, key pillars of old age
care. Moreover, they have been instrumen-
tal in developing and refining national
curricula and postgraduate training com-
petencies as well as continuing professional
development opportunities. A consider-
able work to raise awareness and interest
in Geriatric Medicine has also been con-
ducted in medical schools. There is some
evidence that targeted teaching and learn-
ing activities might increase the likelihood
of undergraduate students to consider a
career in Geriatric Medicine (4). At first
glance, the expansion of the specialty seems
commensurate to the progressive increase
in the number of older adults worldwide
(2). However, dedicated care of older adults
has barely developed in many other coun-
tries. This picture is unlikely to change
substantially within the next 10 years.
Geriatricians often subspecialize in
areas of interest and/or local needs, e.g.,
falls, dementia, and incontinence services.
Yet, they maintain solid collaborative links
with other specialties, e.g., orthopedics,
neurology, and psychiatry, and perform
their duties both in hospital and in the
community. Although this multitasking
approach is laudable, there are increasing
concerns about the capacity of the specialty
to consistently deliver excellent care in so
many different domains. A key factor is
represented by the increasing short- and
long-term needs of older people. Such
needs go far beyond the pharmacologi-
cal and non-pharmacological management
of acute and chronic disease conditions
and depend, at least in part, on a num-
ber of factors directly associated with the
aging process itself. First, there is a progres-
sive reduction in the homeostatic capacity
of different organs and systems (5). This
might be due to a “physiologic” reduction
in organ function, e.g., glomerular filtra-
tion rate, as well as co-morbid conditions
and/or use of medications affecting organ
function per se. As a result, the capacity
of older adults to recover after an illness
can be significantly affected. This might
lead to a prolonged hospital stay, a reha-
bilitation period, or the need for ongo-
ing medical and/or social support in the
community. Second, there is an increased
inter-individual variability in several phys-
iological parameters as well as markers of
organ function (6–9). This makes the stan-
dardization of diagnostic and therapeutic
algorithms, well entrenched in the modus
operandi of current healthcare systems,
hard to justify in this population. More-
over, it further limits a clinician’s ability to
predict the short- and long-term outcomes
of different patients suffering from similar
disease conditions. Third, the same disease
condition might present with fairly differ-
ent symptoms and signs in an older patient
vs. a young or a middle-age patient (10,
11). The clinical presentation is often char-
acterized by vague and non-specific com-
plaints, adding further complexity during
the diagnostic process.
It is also worth noting that, with time,
geriatricians have been actively managing
an increasing number of disease condi-
tions. The concept of “geriatric giants,”
including falls, confusion, incontinence,
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and immobility, has been progressively
replaced by one denoting a comprehensive
assessment and management of patients
often suffering from multiple chronic dis-
ease conditions. For example, patients
with chronic obstructive pulmonary dis-
ease and/or heart failure, once managed
primarily by respiratory physicians and
cardiologists, attend geriatric services on
a daily basis. Moreover, conditions previ-
ously unknown amongst older adults, e.g.,
acquired immunodeficiency syndrome, are
becoming an increasing issue in this pop-
ulation. This has implications for disease
management as well as detection and mon-
itoring of drug-related toxicity (12, 13).
A comprehensive assessment and man-
agement plan for an older patient often
requires concerted action by a number
of additional professional groups such
as nursing staff, physiotherapists, occupa-
tional therapists, rehabilitation physicians,
and social carers. This multidisciplinary
approach aims to provide longitudinal,
proactive, and coordinated care to com-
plex patients. However, limited access to
these services might significantly prevent
the accomplishment of such goals. In this
regard, a recent UK report raises significant
concerns about the social care funding cri-
sis (14). The latter is the result of an increas-
ing demand, particularly for people aged
85 years and over, as well as a reduction
in public funding for social care. Funding
projections, accounting for inflation, esti-
mate that the same amount of care in 2010–
2011 would cost GBP 2.57 billion more in
2015–2016 and GBP 4.45 billion more in
2020–2021. Perhaps more worryingly, such
figures do not account for the inevitable
increase in the older population, and the
related demands, during the same period.
Other developed countries are facing simi-
lar issues with reduced healthcare funding
and staff shortages (15–18). Moreover, staff
relocation to acute services in many health-
care organizations is likely to further affect
the capacity to adequately plan, monitor,
and ultimately deliver effective long-term
care for older people suffering from com-
plex disease conditions and various social
circumstances.
Geriatric Medicine has played a key role
in the development of dedicated clinical
protocols and services, e.g., falls preven-
tion clinics and programs, memory clinics,
comprehensive geriatric assessment, and
home visits, in different healthcare set-
tings. Although there is good evidence of
a meaningful clinical and socioeconomic
impact for some of these services (19),
some uncertainty remains with others (20,
21). This highlights the ongoing need for
testing and monitoring established as well
as novel management strategies in this
complex population. An increased focus
on older patients with multiple comorbidi-
ties as a more representative study group
in clinical trials and clinical research has
been advocated (22). However, there are
a number of important issues that need
to be considered, particularly in studies
involving pharmacological agents (23). Tri-
als in older people have focused on tra-
ditional, disease-specific, end-points, e.g.,
heart failure related hospitalizations or
stroke recurrence. The clinical relevance
of such outcomes is uncertain in a pop-
ulation characterized by significant inter-
individual variability and complex patterns
of co-morbidity (24). Instead, a number
of “universal” outcomes such as dyspnea,
fatigue, and physical function are likely to
encompass a number of different, yet com-
mon, disease conditions, and to indicate
a stronger impact of intervention strate-
gies on overall wellbeing in this group. The
use of unconventional end-points, how-
ever, carries potential issues with defini-
tion and standardization, particularly in
the presence of cognitive impairment (25).
A key factor driving both current and
future research agendas in healthy aging
is the active involvement of end users,
i.e., older adults, in identifying and refin-
ing research questions and outcomes of
interest. According to two recent national
surveys, conducted by the Disabled Liv-
ing Foundation Charity in the UK and by
the Home Instead Senior Care network in
USA, respectively, older adults’ biggest fear
is the loss of independence and moving
into an institution, rather than dying (26,
27). Apart from the obvious consequences
on psychological wellbeing and interper-
sonal relationships, loss of independence
carries significant economic implications
for healthcare systems. In USA, it has been
estimated that the transition from being
fully independent to needing help with
≥1 activity of daily living, but still liv-
ing at home, increased the total annual
health care spending per person from USD
4,771 to USD 18,025. The transition into a
nursing home increased the annual cost to
a staggering USD 36,596 (28).
Are there endogenous or external fac-
tors favoring the loss of independence,
in addition to the consequences of well-
known disease states, e.g., stroke, in older
adults? Their identification might help
developing better strategies to maintain
an active and independent lifestyle in this
population. Recent evidence suggests that
iatrogenic factors, e.g., medications, frailty,
and sarcopenia play a key role in this
context. Prescribing of drugs with anti-
cholinergic (antimuscarinic) and/or seda-
tive effects has been shown to be indepen-
dently associated with physical and cogni-
tive decline. Moreover, it predicts adverse
short- and long-term outcomes in older
people (29–34). Changes in cognitive and
physical function, often subtle, might be
erroneously attributed to the aging process
per se, rather than medications (35). Frailty
and sarcopenia are also important markers
of impaired homeostasis and susceptibility
to either acute or chronic disease states (36,
37). Although there is no universal consen-
sus on their definition,both frailty and sar-
copenia independently predict adverse out-
comes in older patient subgroups (38–41).
The emerging biological and clinical
role of factors negatively affecting inde-
pendence is likely to boost experimen-
tal, translational, and clinical research to
identify the mechanisms involved as well
as potential preventive and management
strategies. Although“de-prescribing” inter-
ventions to reduce inappropriate exposure
to anticholinergic and sedative drugs have
been conducted with some success, their
effects on cognitive and/or physical func-
tion are far from established (42,43). More-
over, relatively little is known about the
exact mechanisms responsible for the onset
and progression of functional decline with
these drugs. These important issues should
be addressed in future studies. Similarly,
current and novel experimental models
of frailty and sarcopenia might lead to
the identification of nutritional, pharma-
cological, and life-style interventions to be
further tested in clinical trials (44, 45).
Geriatric Medicine and, more gener-
ally, research into aging face a number of
challenges. The continuing expansion of
the older population worldwide, together
with the increasing exposure to new drugs
and clinical conditions will require a
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regular review of the specialty aims, direc-
tions, work philosophy, and social impact.
The further development, validation, and
implementation of national curricula and
core competencies will hopefully ensure a
continuing interest of current and future
generations of medical graduates in geri-
atric care and related medical specialties.
This is particularly important at a time of
economic uncertainty and resource alloca-
tion. Such challenges, however, might also
represent exciting opportunities for iden-
tifying novel mechanisms of disease and
frailty as well as testing pharmacological
and/or non-pharmacological interventions
on investigator – as well as patient-driven
outcomes in adequate and representative
study groups. As previously discussed, the
identification of “universal” outcomes is
likely to better reflect the impact of specific
interventions on wellbeing and quality of
life (24). Frontiers in Medicine, an innov-
ative scientific medical journal and forum
for ongoing debate amongst peers, is per-
haps launched at the right time to facilitate
some of these steps.
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